Weighted Average Number of Shares Outstanding, Basic of Immunovant, Inc. from 30 Jun 2020 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Immunovant, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 30 Jun 2020 to 31 Dec 2025.
  • Immunovant, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 31 Dec 2025 was 181,513,386, a 24% increase year-over-year.
  • Immunovant, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 151,573,553, a 9.8% increase from 2023.
  • Immunovant, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 138,100,577, a 12% increase from 2022.
  • Immunovant, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 123,075,329, a 12% increase from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Immunovant, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 181,513,386 +34,591,048 +24% 01 Oct 2025 31 Dec 2025 10-Q 06 Feb 2026 2026 Q3
Q3 2025 173,643,829 +27,174,838 +19% 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025 2026 Q2
Q2 2025 170,872,994 +24,787,265 +17% 01 Apr 2025 30 Jun 2025 10-Q 11 Aug 2025 2026 Q1
Q1 2025 151,573,553 +13,472,976 +9.8% 01 Jan 2025 31 Mar 2025 10-K 29 May 2025 2025 FY
Q4 2024 146,922,338 +2,399,304 +1.7% 01 Oct 2024 31 Dec 2024 10-Q 06 Feb 2026 2026 Q3
Q3 2024 146,468,991 +15,313,349 +12% 01 Jul 2024 30 Sep 2024 10-Q 10 Nov 2025 2026 Q2
Q2 2024 146,085,729 +15,582,465 +12% 01 Apr 2024 30 Jun 2024 10-Q 11 Aug 2025 2026 Q1
Q1 2024 138,100,577 +15,025,248 +12% 01 Jan 2024 31 Mar 2024 10-K 29 May 2025 2025 FY
Q4 2023 144,523,034 +15,948,844 +12% 01 Oct 2023 31 Dec 2023 10-Q 06 Feb 2025 2025 Q3
Q3 2023 131,155,642 +14,582,822 +13% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2025 Q2
Q2 2023 130,503,264 +13,945,756 +12% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024 2025 Q1
Q1 2023 123,075,329 +13,396,073 +12% 01 Jan 2023 31 Mar 2023 10-K 29 May 2025 2025 FY
Q4 2022 128,574,190 +13,548,999 +12% 01 Oct 2022 31 Dec 2022 10-Q 12 Feb 2024 2024 Q3
Q3 2022 116,572,820 +7,494,393 +6.9% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2024 Q2
Q2 2022 116,557,508 +18,580,526 +19% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2024 Q1
Q1 2022 109,679,256 +21,922,743 +25% 01 Jan 2022 31 Mar 2022 10-K 22 May 2023 2023 FY
Q4 2021 115,025,191 +17,104,731 +17% 01 Oct 2021 31 Dec 2021 10-Q 03 Feb 2023 2023 Q3
Q3 2021 109,078,427 +24,724,989 +29% 01 Jul 2021 30 Sep 2021 10-Q 04 Nov 2022 2023 Q2
Q2 2021 97,976,982 +27,158,115 +38% 01 Apr 2021 30 Jun 2021 10-Q 05 Aug 2022 2023 Q1
Q1 2021 87,756,513 01 Jan 2021 31 Mar 2021 10-K 08 Jun 2022 2022 FY
Q4 2020 97,920,460 01 Oct 2020 31 Dec 2020 10-Q 04 Feb 2022 2022 Q3
Q3 2020 84,353,438 01 Jul 2020 30 Sep 2020 10-Q 05 Nov 2021 2021 Q2
Q2 2020 70,818,867 01 Apr 2020 30 Jun 2020 10-Q 09 Aug 2021 2021 Q1

Immunovant, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 151,573,553 +13,472,976 +9.8% 01 Apr 2024 31 Mar 2025 10-K 29 May 2025 2025 FY
2023 138,100,577 +15,025,248 +12% 01 Apr 2023 31 Mar 2024 10-K 29 May 2025 2025 FY
2022 123,075,329 +13,396,073 +12% 01 Apr 2022 31 Mar 2023 10-K 29 May 2025 2025 FY
2021 109,679,256 +21,922,743 +25% 01 Apr 2021 31 Mar 2022 10-K 22 May 2023 2023 FY
2020 87,756,513 01 Apr 2020 31 Mar 2021 10-K 08 Jun 2022 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.